Ipsen releases positive phase II aesthetic dermatology data

Pharmaceutical group Ipsen releases positive phase II data in glabellar wrinkles treatment.

Published 9sem1 sourceNotable

≈ 17sSpeed

The fact

The clinical results strengthen its aesthetic portfolio and open new commercial opportunities.

Trial success reinforces market confidence in Ipsen's therapeutic diversification strategy.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 18, 2026